Research Group Niessing

Dierk Niessing

  • Since 10/2017: Full Professor and Head of the Institute for Pharmaceutical Biotechnology at the Ulm University

  • Since 09/2016: Advisory committee member of patient registry for the PURA syndrome

  • Since 01/2016: Speaker of DFG Research Unit FOR2333

  • 2016-2017: Elected Member of the
    Center for Advanced Studies (CAS) LMU

  • 2015-2017: W2-Professor at the Medical Faculty of the LMU
  • 2013: Habilitation in "Biochemistry" at the LMU
  • Since 2010: Deputy Director of the
    Institute of Structural Biology
  • 2009: Tenure at the Helmholtz Zentrum München
  • 2005-2009: Leader of Helmholtz-University-University
    Young Investigators Group

  • 2003-2005: Postdoctoral Fellow at SGX-Parmarceuticals, Inc.
    San Diego, USA (Structural Biology, Biophysics)

  • 2000-2002: Postdoctoral Fellow at The Rockefeller University
    New York, USA (Structural Biology, Biophysics)

  • 1996-2000: PhD at the Max-Planck Institute for Biophysical Chemistry
    Göttingen, Germany (Developmental Biology, Genetics)

  • 1990-1996: Studies at Faculty of Natural Sciences (Biology)
    Georgia Augusta University Göttingen, Germany

 

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.